Report cover image

APAC Pharmacogenetic Testing Market - Industry Trends and Forecast to 2031

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 208 Pages
SKU # DAABD18360504

Description

APAC Pharmacogenetic Testing Market - Industry Trends and Forecast to 2031


The Asia-Pacific pharmacogenetic testing market is expected to reach USD 2,049.35 million by 2030 from USD 970.29 million in 2022, growing at a CAGR of 10.0% during the forecast period of 2023 to 2030.

Market Segmentation
Asia-Pacific Pharmacogenetic Testing Market, By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, and Single Gene Tests), Gene Type (CYP2C19, CYP2D6, CYP2C9 AND VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, CYP2D, OPRM1, ONCOTYPE DX AND MAMMAPRINT, DRD3, D4D4, SLC6A4, HTR2A/C, TMPT, and Others), Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, and Over-the-Counter Medications), Sample (Blood and Saliva), Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Gynecology, Oncology, Neurology, and Others), Application (Clinical Practice, Drug Development, and Drug Regulation), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Centres and Academic Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, and Direct-to-Customer Services), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and rest of Asia-Pacific) - Industry Trends and Forecast to 2030

Overview of Global Pharmacogenetic Testing Market Dynamics

Driver
• Rapid technological advancement and miniaturization
Restrain

• Environment and health concerns
Opportunity

• Rising research and development and innovative technologies

Market Players

Some of the major market players operating in the Asia-Pacific pharmacogenetic testing market are:

• Thermo Fisher Scientific
• Sonic Healthcare
• BGI
• QIAGEN
• Illumina, Inc

Table of Contents

208 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia Pacific Pharmacogenetic Testing Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Dbmr Market Position Grid
2.7 Multivariate Modelling
2.8 Type Lifeline Curve
2.9 Market End User Coverage Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’sfive Forces
4.3 Industry Insights And Strategic Analysis
5 Market Overview
5.1 Drivers
5.1.1 Increasing Adoption Of Personalized Medicine
5.1.2 Advancements In Genomic Technologies
5.1.3 Increasing Chronic And Complex Diseases
5.1.4 Role Of Pharmacogenetic Testing In Drug Discovery And Development
5.2 Restraints
5.2.1 Dependency On The Medical And Genomic Expert For Result Interpretation
5.2.2 Ethical And Privacy Concerns Associated With Pharmacogenetic Testing
5.3 Opportunities
5.3.1 Integration With Electronic Health Records (Ehrs)
5.3.2 Artificial Intelligence (Ai) And Machine Learning Integration In Healthcare
5.4 Challenges
5.4.1 Challenges In Clinical Implementation Of Pharmacogenetics
5.4.2 Complexity Associated With Pharmacogenetic Testing Results
6 Asia Pacific Pharmacogenetic Testing Market, By Type
6.1 Overview
6.2 Whole Genome Sequencing
6.2.1 Next Generation Sequencing (Ngs)
6.2.2 Sanger Sequencing
6.3 Whole Exome Sequencing
6.3.1 Next Generation Sequencing (Ngs)
6.3.2 Sanger Sequencing
6.4 Array-based Tests
6.4.1 Glass Slide Arrays
6.4.2 In—situ Synthesized Arrays
6.4.3 Self Assembled Arrays
6.5 Single Gene Tests
6.5.1 Next Generation Sequencing (Ngs)
6.5.2 Sanger Sequencing
7 Asia Pacific Pharmacogenetic Testing Market, By Gene Type
7.1 Overview
7.2 Cyp2c19
7.3 Cyp2d6
7.4 Cyp2c9 And Vkorc1
7.5 Cyp1a2
7.6 Hla-b*1502
7.7 Hla-b*5701
7.8 Cyp2d
7.9 Oprm1
7.10 Oncotype Dx* And Mammaprint
7.11 Drd3
7.12 D4d4
7.13 Slc6a4
7.14 Htr2a/C
7.15 Tmpt
7.16 Others
8 Asia Pacific Pharmacogenetic Testing Market, By Drug Type
8.1 Overview
8.2 Prescription Drugs
8.3 Nutraceuticals
8.4 Recreational Drugs
8.5 Herbal Supplements
8.6 Vitamins
8.7 Over-the-counter Medications
9 Asia Pacific Pharmacogenetic Testing Market, By Sample
9.1 Overview
9.2 Blood
9.3 Saliva
10 Asia Pacific Pharmacogenetic Testing Market, By Therpaeutic Area
10.1 Overview
10.2 Cardiology
10.3 Gastroenterology
10.4 Anesthesiology
10.5 Genomics
10.6 Endocrinology
10.7 Immunology & Hypersensitivity
10.8 Dermatology
10.9 Gynecology
10.10 Oncology
10.11 Neurology
10.12 Others
11 Asia Pacific Pharmacogenetic Testing Market, By Application
11.1 Overview
11.2 Clinical Practice
11.2.1 Side Effects
11.2.2 Drug Effectiveness
11.2.3 Dosage
11.3 Drug Development
11.3.1 Drug Effectiveness
11.3.2 Dosage
11.3.3 Side Effects
11.4 Drug Regulation
11.4.1 Side Effects
11.4.2 Drug Effectiveness
11.4.3 Dosage
12 Asia Pacific Pharmacogenetic Testing Market, By End User
12.1 Overview
12.2 Healthcare Providers
12.3 Pharmaceutical & Biotechnology Companies
12.4 Research Centres And Academic Institutes
12.5 Others
13 Asia Pacific Pharmacogenetic Testing Market, By Distribution Channel
13.1 Overview
13.2 Hospital Pharmacy
13.3 Retail Pharmacies
13.4 Mail-order Pharmacies
13.5 Direct-to-customer Services
14 Asia Pacific Pharmacogenetic Testing Market, By Region
14.1 Asia-pacific
15 Asia Pacific Pharmacogenetic Testing Market: Company Landscape
15.1 Company Share Analysis: Asia Pacific
16 Swot Analysis
17 Company Profile
17.1 Thermo Fisher Scientific Inc.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Developments
17.2 Illumina, Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Qiagen
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Sonic Healthcare
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Bgi
17.5.1 Company Snapshot
17.5.2 Company Share Analysis
17.5.3 Product Portfolio
17.5.4 Recent Development
17.6 23andme, Inc
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Development
17.7 Dynamic Dna Laboratories
17.7.1 Company Snapshot
17.7.2 Product Portfolio
17.7.3 Recent Development
17.8 Eurofins Scientific (2022)
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Genewix (A Subsidiary Of Azenta Life Science)
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Luminex Corporation (A Sunbsidiary Of Diasorin)
17.10.1 Company Snapshot
17.10.2 Product Portfolio
17.10.3 Recent Development
17.11 Md Labs
17.11.1 Company Snapshot
17.11.2 Product Portfolio
17.11.3 Recent Development
17.12 Myriad Genetics, Inc.
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.12.4 Recent Developments
17.13 Oneome
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 Pacbio
17.14.1 Company Snapshot
17.14.2 Revenue Analysis
17.14.3 Product Portfolio
17.14.4 Recent Development
17.15 Perkinelmer Inc.
17.15.1 Company Snapshot
17.15.2 Revenue Analysis
17.15.3 Product Portfolio
17.15.4 Recent Development
17.16 Pgxt
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 Asia Pacific Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 2 Asia Pacific Whole Genome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 3 Asia Pacific Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 4 Asia Pacific Whole Exome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 5 Asia Pacific Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 6 Asia Pacific Array-based Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 7 Asia Pacific Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 8 Asia Pacific Single Gene Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 9 Asia Pacific Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 10 Asia Pacific Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 11 Asia Pacific Cyp2c19 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 12 Asia Pacific Cyp2d6 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 13 Asia Pacific Cyp2c9 And Vkorc1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 14 Asia Pacific Cyp1a2 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 15 Asia Pacific Hla-b*1502 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 16 Asia Pacific Hla-b*5701 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 17 Asia Pacific Cyp2d In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 18 Asia Pacific Oprm1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 19 Asia Pacific Oncotype Dx* And Mammaprint In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 20 Asia Pacific Drd3 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 21 Asia Pacific D4d4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 22 Asia Pacific Slc6a4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 23 Asia Pacific Htr2a/C In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 24 Asia Pacific Tmpt In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 25 Asia Pacific Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 26 Asia Pacific Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 27 Asia Pacific Prescription Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 28 Asia Pacific Nutraceuticals In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 29 Asia Pacific Recreational Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 30 Asia Pacific Herbal Supplements In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 31 Asia Pacific Vitamins In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 32 Asia Pacific Over-the-counter Medications In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 33 Asia Pacific Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 34 Asia Pacific Blood In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 35 Asia Pacific Saliva In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 36 Asia Pacific Pharmacogenetic Testing Market, By Therpaeutic Area, 2021-2030 (Usd Million)
Table 37 Asia Pacific Cardiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 38 Asia Pacific Gastroenterology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 39 Asia Pacific Anesthesiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 40 Asia Pacific Genomics In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 41 Asia Pacific Endocrinology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 42 Asia Pacific Immunology & Hypersensitivity In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 43 Asia Pacific Dermatology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 44 Asia Pacific Gynecology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 45 Asia Pacific Oncology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 46 Asia Pacific Neurology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 47 Asia Pacific Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 48 Asia Pacific Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 49 Asia Pacific Clinical Practice In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 50 Asia Pacific Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 51 Asia Pacific Drug Development In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 52 Asia Pacific Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 53 Asia Pacific Drug Regulation In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 54 Asia Pacific Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 55 Asia Pacific Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 56 Asia Pacific Healthcare Providers In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 57 Asia Pacific Pharmaceutical & Biotechnology Companies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 58 Asia Pacific Research Centres And Academic Institutes In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 59 Asia Pacific Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 60 Asia Pacific Pharmacogenetic Testing Market, By Distribution Channel, 2020-2030 (Usd Million)
Table 61 Asia Pacific Hospital Pharmacy In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 62 Asia Pacific Retail Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 63 Asia Pacific Mail-order Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 64 Asia Pacific Direct-to-customer Services In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 65 Asia-pacific Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million)
Table 66 Asia-pacific Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 67 Asia-pacific Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 68 Asia-pacific Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 69 Asia-pacific Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 70 Asia-pacific Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 71 Asia-pacific Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 72 Asia-pacific Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 73 Asia-pacific Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 74 Asia-pacific Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 75 Asia-pacific Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 76 Asia-pacific Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 77 Asia-pacific Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 78 Asia-pacific Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 79 Asia-pacific Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 80 Asia-pacific Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 81 Japan Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 82 Japan Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 83 Japan Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 84 Japan Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 85 Japan Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 86 Japan Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 87 Japan Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 88 Japan Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 89 Japan Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 90 Japan Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 91 Japan Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 92 Japan Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 93 Japan Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 94 Japan Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 95 Japan Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 96 China Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 97 China Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 98 China Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 99 China Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 100 China Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 101 China Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 102 China Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 103 China Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 104 China Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 105 China Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 106 China Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 107 China Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 108 China Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 109 China Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 110 China Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 111 South Korea Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 112 South Korea Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 113 South Korea Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 114 South Korea Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 115 South Korea Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 116 South Korea Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 117 South Korea Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 118 South Korea Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 119 South Korea Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 120 South Korea Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 121 South Korea Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 122 South Korea Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 123 South Korea Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 124 South Korea Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 125 South Korea Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 126 India Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 127 India Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 128 India Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 129 India Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 130 India Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 131 India Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 132 India Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 133 India Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 134 India Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 135 India Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 136 India Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 137 India Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 138 India Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 139 India Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 140 India Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 141 Australia Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 142 Australia Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 143 Australia Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 144 Australia Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 145 Australia Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 146 Australia Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 147 Australia Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 148 Australia Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 149 Australia Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Asia Pacific Pharmacogenetic Testing Market: Segmentation
Figure 2 Asia Pacific Pharmacogenetic Testing Market: Data Triangulation
Figure 3 Asia Pacific Pharmacogenetic Testing Market: Droc Analysis
Figure 4 Asia Pacific Pharmacogenetic Testing Market: Asia Pacific Vs Regional Market Analysis
Figure 5 Asia Pacific Pharmacogenetic Testing Market: Company Research Analysis
Figure 6 Asia Pacific Pharmacogenetic Testing Market: Interview Demographics
Figure 7 Asia Pacific Pharmacogenetic Testing Market: Dbmr Market Position Grid
Figure 8 Asia Pacific Pharmacogenetic Testing Market: Market End User Coverage Grid
Figure 9 Asia Pacific Pharmacogenetic Testing Market: Segmentation
Figure 10 Increasing Adoption Of Personalized Medicine Is Driving The Growth Of The Asia Pacific Pharmacogenetic Testing Market In The Forecast Period Of 2023 To 2030
Figure 11 Whole Genome Sequencing Segment Is Expected To Account For The Largest Share Of The Asia Pacific Pharmacogenetic Testing Market In 2023 & 2030
Figure 12 Drivers, Restraints, Opportunities, And Challenges Of Asia Pacific Pharmacogenetic Testing Market
Figure 13 Asia Pacific Pharmacogenetic Testing Market: By Type, 2022
Figure 14 Asia Pacific Pharmacogenetic Testing Market: By Type, 2023-2030 (Usd Million)
Figure 15 Asia Pacific Pharmacogenetic Testing Market: By Type, Cagr (2023-2030)
Figure 16 Asia Pacific Pharmacogenetic Testing Market: By Type, Lifeline Curve
Figure 17 Asia Pacific Pharmacogenetic Testing Market: By Gene Type, 2022
Figure 18 Asia Pacific Pharmacogenetic Testing Market: By Gene Type, 2023-2030 (Usd Million)
Figure 19 Asia Pacific Pharmacogenetic Testing Market: By Gene Type, Cagr (2023-2030)
Figure 20 Asia Pacific Pharmacogenetic Testing Market: By Gene Type, Lifeline Curve
Figure 21 Asia Pacific Pharmacogenetic Testing Market: By Drug Type, 2022
Figure 22 Asia Pacific Pharmacogenetic Testing Market: By Drug Type, 2023-2030 (Usd Million)
Figure 23 Asia Pacific Pharmacogenetic Testing Market: By Drug Type, Cagr (2023-2030)
Figure 24 Asia Pacific Pharmacogenetic Testing Marke

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us